Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026)
Sunshine Biopharma's (SBFM) quarterly Inventory Average came in at $13.3 million in Q1 2026, up 15.15% YoY from $11.6 million in Q1 2025, and down 3.25% on a QoQ basis from $13.8 million in Q4 2025.
Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 8 years of Inventory Average data on file, last reported at $13.3 million in Q1 2026.
- Quarterly Inventory Average rose 15.15% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 15.15% YoY) and the FY2025 annual result came in at $12.4 million, up 45.48% from the prior year.
- Inventory Average slipped to $13.3 million in Q1 2026, from $13.8 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $13.8 million in Q4 2025 to a low of $143573.0 in Q1 2022.
- A 5-year average of $7.0 million and a median of $6.7 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average surged 2337.76% — and 2026, when it grew 15.15%.
- Tracing SBFM's Inventory Average over 5 years: stood at $1.8 million in 2022, then jumped by 188.01% to $5.1 million in 2023, then soared by 105.81% to $10.5 million in 2024, then jumped by 30.51% to $13.8 million in 2025, then decreased by 3.25% to $13.3 million in 2026.
- The last three Inventory Average figures came in at $13.3 million (Q1 2026), $13.8 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | 12.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.65 Mn |
| Mar 31, 2026 | 13.32 Mn |
| Dec 31, 2025 | 13.77 Mn |
| Sep 30, 2025 | 13.54 Mn |
| Jun 30, 2025 | 12.44 Mn |
| Mar 31, 2025 | 11.57 Mn |
| Dec 31, 2024 | 10.55 Mn |
| Sep 30, 2024 | 9.16 Mn |
| Jun 30, 2024 | 8.09 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 5.13 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 237,506.00 |
| Jun 30, 2022 | 193,433.50 |
| Mar 31, 2022 | 143,573.00 |
| Dec 31, 2021 | 88,480.00 |
| Sep 30, 2021 | 58,263.50 |